Danaher Corporation (DHR) Earnings Call Analysis

NYSE · Healthcare · Diagnostics & Research

25/25

Growth 5 Margin 5 Expansion 5 Platform 5 Financial 5

latest quarter score

Earnings Reports

25
Danaher (DHR) Q2 2026: Core Growth Ex-Respiratory Accelerates to 4.5% as Life Sciences Outpaces Bioprocessing Delays
July 21, 2026
22
Danaher (DHR) Q1 2026: Bioprocessing Equipment Orders Jump 30%, Signaling Early Cycle Turn
April 21, 2026
23
Danaher (DHR) Q4 2025: Bioprocessing Core Up High Single Digits, Setting 2026 Growth Floor
January 28, 2026
23
Danaher (DHR) Q3 2025: Bioprocessing Core Up 6.5%, Margin Expansion Sets Up 100bps+ 2026 Leverage
October 21, 2025
25
Danaher (DHR) Q2 2025: Bioprocessing Climbs 6% as Equipment Lag and Tariff Uncertainty Cap Upside
July 23, 2025
25
Danaher (DHR) Q1 2025: Bioprocessing Orders Up 7th Consecutive Quarter, Offsetting Tariff Drag
July 01, 2025

Browse all companies